Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Early Phase 1 Study of ABT-888 in Combination With Carboplatin and Paclitaxel in Patients With Hepatic or Renal Dysfunction and Solid Tumors

NCT01366144 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT01366144
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01366144 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Early Phase 1 Study of ABT-888 in Combination With Carboplatin and Paclitaxel in Patients With Hepatic or Renal Dysfunction and Solid Tumors
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 1
Overall status
Active, not recruiting
Start date
June 20, 2011
Completion date
March 3, 2027
Enrollment
94 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

breast carcinoma, carcinoma of unknown primary, endometrial carcinoma, esophageal carcinoma, liver failure, lung carcinoma, malignant head and neck neoplasm, malignant testicular neoplasm, melanoma, metastatic malignant solid neoplasm, ovarian carcinoma, renal failure, unresectable malignant neoplasm, urothelial carcinoma